Saxenda is Novo Nordisk's brand of liraglutide for chronic weight management. Daily subcutaneous injection. Less commonly prescribed today than weekly semaglutide or tirzepatide options.
At a glance
- Generic name: liraglutide
- Manufacturer: Novo Nordisk
- List price: not re-checked in October 2026; see the manufacturer's pricing page
- Cash-pay program: NovoCare patient assistance
FDA-approved indications
- Chronic weight management (2014)
- Pediatric obesity 12+ (2020)
Standard dosing
- Start: 0.6 mg daily × 1 wk
- Titration: weekly increases by 0.6 mg
- Maintenance: 3.0 mg daily